Old Web
English
Sign In
Acemap
>
authorDetail
>
Y. M. Extra
Y. M. Extra
Neutropenia
Phases of clinical research
Regimen
Medicine
Pharmacology
1
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studies
1996
Annals of Oncology
Jean-Pierre Armand
Y. M. Extra
G. Catimel
D Abigerges
Michel Marty
M. Clavel
Show All
Source
Cite
Save
Citations (28)
1